Dr. Tapinos receives Brown Biomedical Innovation fund for developing the eRNA therapeutics targeting the glioblastoma

“The Tapinos lab has shown that some specific members of a class of molecular targets known as enhancer RNA (eRNA) are important for growth of GSCs. He will use BBII funds to discover and develop drugs to interfere with these eRNAs and stop the growth of GSCs and change the treatment course for glioblastoma.”

Link is here